Transitioning from High-Flow Nasal Cannula to Conventional Oxygen Therapy

Clinical Criteria for Transition

The European Respiratory Society recommends switching from high-flow nasal cannula (HFNC) to conventional oxygen therapy (COT) when the patient demonstrates sustained clinical improvement with oxygen requirements that can be met by low-flow oxygen, stable respiratory rate, minimal work of breathing, and oxygen saturation consistently maintained at target levels (94-98% for non-hypercapnic patients or 88-92% for those at risk of hypercapnia) 1, 2
Respiratory rate should be normalized, typically <20-22 breaths/min, as HFNC effectively reduces respiratory rate by mean 2.25 breaths/min 3
Work of breathing should be minimal, with no accessory muscle use, and the patient should appear comfortable without signs of respiratory distress 2
Oxygen saturation should be stable, consistently meeting target SpO2 (94-98% for most patients, 88-92% for hypercapnic risk) on reduced FiO2 settings 2

FiO2 should be weaned to ≤0.40 (40%) while maintaining adequate oxygenation on progressively lower oxygen concentrations 1, 2
Flow rate should be reduced to 30-35 L/min or lower, and if the patient remains stable, they may be candidates for COT 2
Improved gas exchange should be observed, with PaO2 values stable or improving, and PaO2/FiO2 ratio >200-300 mmHg if arterial blood gases are obtained 4, 3

Symptom resolution should be observed, with dyspnea significantly improved or resolved, as HFNC reduces dyspnea (SMD 0.32 lower) 3
Patient comfort should be maintained, with the patient reporting feeling comfortable and not experiencing increased work of breathing 3, 2
Underlying condition should be improving, with the acute hypoxemic respiratory failure resolving based on clinical and radiographic findings 1, 5

The patient should be stable on HFNC for at least 12-24 hours before attempting to transition to COT 2
FiO2 should be ≤0.40 and flow rate ≤35 L/min before transitioning to COT 2
Respiratory rate should be <22 breaths/min and SpO2 at target before transitioning to COT 2
Flow rate should be decreased by 5-10 L/min increments while monitoring closely, and FiO2 should be reduced by 5-10% decrements to maintain target SpO2 2
The patient should be observed for 30-60 minutes after each adjustment 2
When the patient tolerates flow ≤30 L/min and FiO2 ≤0.35-0.40, they may be switched to nasal cannula at 2-6 L/min 6, 2

Premature weaning is the most significant risk, and switching too early can lead to clinical deterioration and potential need for escalation to intubation 7, 2
Delayed escalation recognition can lead to inadequate oxygen delivery, and prompt return to HFNC or consideration of escalation to non-invasive ventilation is necessary if hypercapnia develops 8, 2
Ignoring patient-specific factors, such as severe disease or high intubation risk, can lead to inadequate treatment, and these patients should remain on HFNC longer before attempting transition 1, 5
Inadequate monitoring during transition can lead to decompensation, and continuous pulse oximetry and frequent respiratory assessments are essential 2

Immunocompromised patients may require more conservative weaning criteria before transitioning to COT, as they show similar mortality benefits but smaller reductions in intubation rates with HFNC 1, 5
Post-extubation patients may benefit from longer maintenance on HFNC (typically 24-48 hours) before considering COT, as HFNC is particularly beneficial in preventing reintubation 7, 2
In resource-limited settings, earlier transition to COT may be necessary when clinically safe, despite higher oxygen consumption and equipment costs, as HFNC can lead to overall savings by avoiding intubation 1, 5

The European Respiratory Society suggests that the benefits of HFNC may outweigh discomfort in patients at high risk of respiratory complications, with consideration of anastomotic leakage risk when deciding between HFNC and positive pressure ventilation 9, 10
The American Thoracic Society recommends that when patient tolerates flow ≤30 L/min and FiO2 ≤0.35-0.40, switch to nasal cannula at 2-6 L/min, with lower risk of reintubation with HFNC compared to conventional oxygen (4.9% vs 12.2%) 11

The American College of Chest Physicians recommends maintaining HFNC for 24-48 hours before considering transition to conventional oxygen, as HFNC is particularly beneficial in preventing reintubation (risk ratio 0.62) 11